ArticleCancer reports (Hoboken, N.J.)2021

Use of the prostate-specific antigen test in the U.S. for men age 30 to 64 in 2011 to 2017 using a large commercial claims database: Implications for practice interventions.

Shahram Shahangian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.